Study on the synthesis and cytotoxicity of new quinophenoxazine derivatives

Chemical and Pharmaceutical Bulletin

Volumn 54, Issue 2, 2006, Pages 248-251

  Kwon, Youngjoo ^a   Na, Younghwa ^b  

^a Ewha Womans University   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

Cytotoxicity; Fluoroquinolone; Quinophenoxazine

Indexed keywords

1 (3 AMINO 1 PYRROLIDINYL) 2 FLUORO 4 OXO 4H QUINO[8,1A,1 B,C][1,4]BENZOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 4 OXO 4H PYRIDO[3,2,1 KL] 1,4 DIOXONAPHTHO[2,3 C]PHENOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 4 OXO 4H PYRIDO[3,2,1 KL] 7 AZAPHENOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 4 OXO 4H PYRIDO[3,2,1 KL] 8 AZAPHENOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 4 OXO 4H PYRIDO[3,2,1 KL]PYRIDINO[3,2 C]PHENOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 8 ALLYOXY 4 OXO 4H PYRIDO[3,2,1 KL]PHENOXAZINE 5 CARBOXYLIC ACID; 1 (3 PYRROLIDIN 1 YL) 2 FLUORO 8 METHOXY 4 OXO 4H PYRIDOL[3,2,1 KL]PHENOXAZINE 5 CARBOXYLIC ACID; ANTINEOPLASTIC AGENT; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

EID: 32044445077     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.54.248     Document Type: Article

References (13)

1. Koga H., Itoh A., Murayama S., Suzue S., Irikura T., J. Med. Chem., 23, 1358-1363 (1980).
2. Wise R., Andrews J. M., Edwards L. J., Antimicrob. Agents Chemother., 23, 559-564 (1983).
3. Bhanot S. K., Singh M., Chartterjee N. R., Curr. Pharm. Des., 7, 313-337 (2001) and references therein.
4. Anderson V. E., Osheroff N., Curr. Pharm. Des., 7, 339-355 (2001).
5. Chu D. T. W., Maleczka R. E., Jr., J. Heterocyclic Chem., 24, 453-456 (1987).
6. Chu. D. T. W., Hallas R., Clement J. J., Alder J., McDonald E., Drugs Exp. Clin. Res., 18, 275-282 (1992).
7. Chu. D. T. W., Hallas R., Tanaka S. K., Alder J., Balli D., Plattner J. J., Drugs Exp. Clin. Res., 20, 177-183 (1994).
8. Zeng Q., Kwok Y., Kerwin S. M., Mangold G., Hurley L. H., J. Med. Chem., 41, 4273-4278 (1998).
9. Duan W., Rangan A., Vankayalapati H., Kim M.-Y., Zeng Q., Sun D., Han H., Federoff O. Y., Nishioka D., Rha S. Y., Izbicka E., Von Hoff D. D., Hurley L. H., Mol. Cancer Ther., 1, 103-120 (2001).
10. Kim M.-Y., Duan W., Gleason-Guzman M., Hurley L. H., J. Med. Chem., 46, 571-583 (2003).
11. 2, EtOH, 80°C, 5 h.
12. Musser J. H., Jones H., Sciortino S., Bailey K., Coutts S. M., Khandwala A., Sonnino-Goldman P., Leibowitz M., Wolf P., Neiss E. S., J. Med. Chem., 28, 1255-1259 (1985).
13. Kim M. Y., Na Y., Vankayalapati H., Gleason-Guzman M., Hurley L. H., J. Med. Chem., 46, 2958-2972 (2003).